Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Learning from lentiviruses.

M Emerman

    Nature Genetics
    |December 30, 1999
    PubMed
    Summary
    This summary is machine-generated.

    Human immunodeficiency virus (HIV)-based vectors can deliver genes to non-dividing cells. However, a new study shows they don't infect all such cells, with host cell activation impacting gene delivery efficiency.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    HIV-1 infection requires a functional integrase NLS.

    Molecular cell·2001
    Same author

    HIV-1 sequence variation: drift, shift, and attenuation.

    Cell·2001
    Same author

    An in vitro rapid-turnover assay for human immunodeficiency virus type 1 replication selects for cell-to-cell spread of virus.

    Journal of virology·2000
    Same author

    Direct detection of infectious HIV-1 in blood using a centrifugation-indicator cell assay.

    Journal of virological methods·2000
    Same author

    A competition model for viral inhibition of host cell proliferation.

    Mathematical biosciences·2000
    Same author

    Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines.

    Journal of virology·1999
    Same journal

    Mapping the path to clinical implementation of multi-omics.

    Nature genetics·2026
    Same journal

    Toward a framework for measuring the impact of ELSI research.

    Nature genetics·2026
    Same journal

    Mutational scanning reveals substrate-assisted autoregulation of the WNT destruction complex.

    Nature genetics·2026
    Same journal

    Spatial transcriptomic analyses highlight distinct erythroid niches in mice and humans.

    Nature genetics·2026
    Same journal

    Building up pangenome analysis block by block.

    Nature genetics·2026
    Same journal

    Mutations in splicing factor gene U2AF1 rescue defective oncogene splicing in KRAS-mutant cancers.

    Nature genetics·2026
    See all related articles

    Area of Science:

    • Gene therapy
    • Virology
    • Cell biology

    Background:

    • Human immunodeficiency virus (HIV)-based vectors are recognized for their capacity to transduce non-proliferative tissues, a key advantage over other gene-delivery vehicles.
    • This characteristic makes them promising tools for therapeutic applications targeting quiescent cell populations.

    Discussion:

    • A recent report challenges the universal efficacy of HIV-based vectors in non-dividing cells.
    • Evidence suggests that not all non-dividing cells are susceptible to infection by these vectors.
    • Host cell activation emerges as a critical factor influencing the efficiency of gene delivery.

    Key Insights:

    • HIV-based vectors exhibit limitations in transducing all non-proliferative cell types.
    • The efficiency of gene delivery is modulated by the activation state of the host cell.

    Related Experiment Videos

  • This finding necessitates a re-evaluation of vector design and application strategies.

    • Outlook:

    • Further research is needed to elucidate the precise mechanisms underlying host cell activation's influence on HIV vector transduction.
    • Optimizing gene delivery to specific non-dividing cell populations may require tailored approaches considering cellular activation states.
    • These insights could pave the way for more effective and targeted gene therapies.